0001161697-23-000185.txt : 20230324 0001161697-23-000185.hdr.sgml : 20230324 20230324170014 ACCESSION NUMBER: 0001161697-23-000185 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230322 FILED AS OF DATE: 20230324 DATE AS OF CHANGE: 20230324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRANDE ALICIA CENTRAL INDEX KEY: 0001402652 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 23760621 MAIL ADDRESS: STREET 1: 220 MIRACLE MILE STREET 2: SUITE 234 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 03-22-2023 X0407 4 2023-03-22 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001402652 GRANDE ALICIA 355 ALHAMBRA CIRCLE, SUITE 801 CORAL GABLES FL 33134 0 1 0 0 VP, Treasurer and CFO 0 Common stock, par value $0.001 per share 2023-03-22 4 M 0 3260 0.79 A 53817 D Common stock, par value $0.001 per share 2023-03-22 4 S 0 3260 16.41 D 50557 D Common stock, par value $0.001 per share 2023-03-22 4 M 0 38524 0.79 A 89081 D Common stock, par value $0.001 per share 2023-03-22 4 S 0 38524 16.51 D 50557 D Options to purchase common stock 0.79 2023-03-22 4 M 0 3260 0 D 2023-06-15 Common Stock 3260 1442574 D Options to purchase common stock 0.79 2023-03-22 4 M 0 38524 0 D 2023-06-15 Common Stock 38524 1404050 D Shares were sold in various lots from $16.40 to $16.425 per share. The listed sale price represents a weighted average price for the shares sold. Shares were sold in various lots from $16.50 to $16.555 per share. The listed sale price represents a weighted average price for the shares sold. Shares were sold to cover exercise price of options, tax withholding requirements and for personal reasons. Shares were not sold as a result of any disagreement with the Company and Ms. Grande remains an officer of the Company. Options vested in two annual tranches beginning on June 15, 2017. /s/ Alicia Grande 2023-03-24